Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model

Doxorubicin (Doxo) is the most effective chemotherapeutic agent for the treatment of breast cancer. However, resistance to Doxo is common. Adjuvant compounds capable of modulating mechanisms involved in Doxo resistance may potentiate the effectiveness of the drug. Resveratrol (Rsv) has been tested a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oxid Med Cell Longev
Asıl Yazarlar: Vargas, José Eduardo, Puga, Renato, Lenz, Guido, Trindade, Cristiano, Filippi-Chiela, Eduardo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2020
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7654215/
https://ncbi.nlm.nih.gov/pubmed/33204396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5432651
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller